PHI with basal cell carcinoma of the skin
How does this condition affect your private health insurance?
Hautbasaliom, or Basal Cell Carcinoma (BCC), is the most common type of skin cancer. It originates from the basal cells in the outermost layer of the skin, typically appearing on sun-exposed areas like the face, neck, and hands. BCC often presents as a pearly, waxy bump, a flat, flesh-colored or brown lesion, or a bleeding sore that heals and returns. While rarely metastasizing, it can be locally destructive, invading surrounding tissues if left untreated. Its primary cause is prolonged exposure to ultraviolet (UV) radiation from sunlight or tanning beds. Early detection and treatment are crucial for a favorable prognosis, usually involving surgical removal.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for growth, then treated (e.g., surgical removal).
Duration of Illness (Lifetime)
Recurrent/chronic, as new lesions can develop over a lifetime, requiring ongoing monitoring.
Cost of Treatment (Initial)
Moderate (e.g., 500-2000 EUR/USD for surgical excision).
Cost of Treatment (Lifetime)
Variable, potentially high for multiple recurrences or advanced cases requiring more extensive procedures.
Mortality Rate
Very low (<0.1%), almost zero if treated early and appropriately.
Risk of Secondary Damages
Low to moderate (e.g., scarring, local tissue damage if untreated or large lesions, psychological distress).
Probability of Full Recovery
Very high (>95%) with early and complete excision of the lesion.
Underlying Disease Risk
Low, but associated with risk factors like fair skin, excessive UV exposure, and sometimes immunosuppression rather than direct underlying diseases.